Market Overview-

With the rise in the global autism disorder & treatment market, there are several barriers faced by the market players such as a weak pipeline of drugs for autism disorder and unknown etiology and pathophysiology of ASD. According to a report published by Market Research future (MRFR), global autism disorder & treatment market share is expected to grow at a 4.4% CAGR during the forecast period 2023 to 2032. The market is estimated to witness significant growth due to the growing acceptance and awareness about global autism disorder among individuals and the improvement in treatment methods for the safety and secure lives of the individuals diagnosed with autism. Additionally, the growing environmental imbalances are also considered to be a factor causing the increasing prevalence of autism disorders.

Autism Spectrum Disorder (ASD) is an array of conditions caused by challenges in speech, social skills, and repetitive behaviors, nonverbal communication, along with unique strengths and differences. This condition is primarily caused by special combinations of genetic and environmental influences. Autism tends to show its most common signs between two and three years of age and can often be diagnosed within 18 months of the child’s birth.

The global autism disorder and treatment market has been accounted as one of the rapidly growing industries, due to rising prevalence of autism and Pervasive Developmental Disorder (PDD) and raising awareness regarding autism among the patients. Autism disorder and treatment market insights is observed as one of the steadily growing markets in the healthcare sector because of government initiatives taken by the various nations and anticipated approvals of various off-label treatment therapy measures by the Food and Drug Association (FDA).

Key Players

global autism disorder & treatment market players are Johnson & Johnson Services, Inc., Pfizer Inc., Eli Lilly, and Company, Merck & CO Inc., Allergan, Saniona AB, Consern Pharma Private Limited, Teva Pharmaceutical Industries Ltd.,Novartis AG, Bristol-Myers Squibb and Otsuka Holdings Co., Ltd., Coronis Partners Ltd., Intra-Cellular Therapies Inc., Heptares Therapeutics Limited, Curemark LLC, and few others.

segmental analysis

The Global autism disorder & treatment market outlook has been segmented based on type, treatment type, and drugs. Based on type, it is segmented into Asperger Syndrome, Pervasive Developmental Disorder, and others.Based on treatment type, it is segmented into ABA (applied behavioral analysis), hyperbaric oxygen therapy, chelation therapy, oxytocin therapy, and others. Based on the drug, it is segmented into SSRIs, anti-convulsant, stimulants, anti-psychotic. Anti-psychotics are segmented into Abilify (aripiprazole) and Risperidone. Based on the region, the market has been segmented into North America, Europe, Asia Pacific, and middle east and Africa.

Regional Analysis

North America has been accounted for the largest market owing to the increase in a number of autism cases in this region. Additionally, the approval and anticipated launch of the atypical anti-psychotic such as Latuda and Namenda is projected to generate increased sales in the U.S. North America is estimated to witness significant growth over the forecast period. The Asia Pacific region is anticipated to be the fastest growing market while the Middle East & Africa show steady and growth during the forecast period. Some of the influential factors responsible for the increasing healthcare facilities in the global autism disorder & treatment market are the expansion of diagnostic criteria, improved awareness, better diagnostic tools, and improved reporting. APAC and Middle and Africa region has started accepting the global autism disorder & treatment market fairly recently due to the lack of awareness in the past years about the disorders, but are estimated to show significant growth due to growing awareness among the consumers.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America